Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
20.20
+0.47 (2.38%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $555.81 million as of September 8, 2026. Its market cap has decreased by -17.28% in one year.
Market Cap
555.81M
Enterprise Value
14.06M
1-Year Change
-17.28%
Ranking
Category
Stock Price
$20.20
ChartMarket Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $555.81M, an increase of 255.15%. That is a compound annual growth rate of 13.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 555.81M | -31.56% |
| Dec 31, 2025 | 812.10M | 43.76% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
| Sep 29, 2016 | 156.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NeoGenomics | 2.23B |
| Personalis | 1.84B |
| Freenome | 1.75B |
| OPKO Health | 1.22B |
| Castle Biosciences | 1.01B |
| Myriad Genetics | 305.12M |
| Biodesix | 276.23M |
| Exagen | 183.63M |